You are seeing these quotes based on previous browsing related to sectors such as
Name | Value | 1 Day Chg | 7 Day Chg | 14 Day Chg | 30 Day Chg | 90 Day Chg | Beta |
---|---|---|---|---|---|---|---|
4basebio | n/a | 4.67% | 8.21% | 17.89% | 17.89% | 71.65% | n/a |
4D Pharma | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Abcam | 134 | 0.00% | -3.24% | -2.23% | -14.03% | -9.39% | n/a |
Abzena | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 93.25% | n/a |
Agronomics Limited | 475 | 1.27% | 3.23% | -3.38% | -7.41% | -20.60% | n/a |
Allergy Therapeutics | 268 | 0.00% | 0.00% | 0.00% | 5.56% | 14.00% | n/a |
Alliance Pharma | 119 | -0.29% | -5.03% | -7.92% | -10.86% | -8.52% | n/a |
Animalcare Group | n/a | 0.00% | 0.00% | 1.40% | 7.43% | 20.56% | n/a |
Anpario | n/a | 0.00% | 2.00% | 4.08% | 9.68% | 0.99% | n/a |
Aptamer Group | n/a | -2.86% | 54.55% | 54.55% | 41.67% | -26.09% | n/a |
Aqua Bounty Technologies Inc. (Reg S) | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Arecor Therapeutics | n/a | 0.00% | 6.23% | -2.50% | -4.55% | -17.77% | n/a |
Argent Biopharma Limited NPV (DI) | n/a | 0.00% | -4.55% | -4.55% | 0.00% | 13.51% | n/a |
AstraZeneca | 123 | 5.94% | 10.19% | 9.71% | 15.19% | 15.10% | n/a |
Avacta Group | 461 | -0.66% | -6.25% | -14.29% | -11.59% | -55.67% | n/a |
Benchmark Holdings | n/a | 5.49% | 10.98% | 11.37% | 6.79% | 13.07% | n/a |
Beximco Pharmaceuticals Ltd. GDR (Reg S) | 190 | 0.00% | 0.00% | 0.00% | -7.59% | 4.29% | n/a |
Biodexa Pharmaceuticals | 386 | 0.00% | -21.05% | -31.82% | -80.26% | -90.38% | n/a |
Biofrontera AG (DI) | n/a | 0.00% | 1.75% | 1.75% | 1.75% | -1.69% | n/a |
Bioventix | n/a | -1.12% | -3.80% | -5.25% | -1.12% | 4.12% | n/a |
BiVictriX Therapeutics | n/a | 0.00% | 0.00% | 2.22% | -2.13% | 0.00% | n/a |
BTG | n/a | 0.00% | 0.12% | 0.30% | 0.42% | 0.60% | n/a |
C4X Discovery Holdings | n/a | 27.32% | 40.35% | 24.03% | -9.09% | -11.44% | n/a |
n/a | 0.00% | 0.00% | 0.00% | 0.00% | -47.06% | n/a | |
Chill Brands Group | 489 | -4.44% | -31.75% | -18.87% | 4.88% | -48.81% | n/a |
Cizzle Biotechnology Holdings | n/a | -2.94% | -5.71% | -8.33% | -19.51% | -34.00% | n/a |
Cyprotex | n/a | 0.00% | 0.63% | 0.78% | 1.26% | 8.81% | n/a |
Dechra Pharmaceuticals | 121 | 0.00% | 0.16% | 0.26% | 0.68% | 1.90% | n/a |
Deepverge Plc | 427 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Destiny Pharma | 410 | -22.09% | -12.99% | -18.29% | -37.96% | -75.19% | n/a |
Diurnal Group | n/a | 0.00% | 0.00% | 0.00% | 0.55% | 176.46% | n/a |
e-Therapeutics | n/a | 4.63% | -3.52% | -11.11% | -18.12% | -41.37% | n/a |
EastPharma Ltd GDR (Reg S) | n/a | 0.00% | -14.29% | -60.00% | 9.09% | 9.09% | n/a |
ECO Animal Health Group | n/a | 9.04% | 9.04% | 9.63% | 21.30% | -6.82% | n/a |
Eden Research | n/a | -2.30% | -12.37% | -15.84% | -8.60% | -29.17% | n/a |
Ergomed | n/a | 0.00% | 0.15% | 0.30% | 0.90% | 22.14% | n/a |
Faron Pharmaceuticals Oy (DI) | n/a | 0.00% | 8.05% | 0.00% | -10.53% | -56.03% | n/a |
Futura Medical | 479 | -1.12% | -0.28% | -1.67% | -6.84% | 16.83% | n/a |
Genflow Biosciences | n/a | 4.84% | 3.17% | 0.00% | 10.17% | -2.99% | n/a |
Genus | 128 | 0.24% | -2.96% | -4.91% | -6.22% | -27.61% | n/a |
GSK | 129 | 0.28% | 3.60% | 0.71% | -3.37% | 7.84% | n/a |
Gunsynd | 527 | 0.00% | 0.00% | -17.24% | -20.00% | -27.27% | n/a |
GW Pharmaceuticals | n/a | 0.00% | -8.13% | -7.72% | -3.35% | 42.30% | n/a |
Haleon | n/a | 0.58% | 3.21% | 2.57% | 1.62% | 6.23% | n/a |
Hemogenyx Pharmaceuticals | 340 | -1.43% | -5.15% | -1.74% | -10.70% | -45.34% | n/a |
Hikma Pharmaceuticals | 125 | 2.26% | 3.63% | 2.04% | -0.56% | -0.62% | n/a |
Horizon Discovery Group | n/a | 0.00% | 0.00% | -1.34% | -4.90% | 86.36% | n/a |
HUTCHMED (China) Limited | 226 | 2.70% | 12.18% | 3.75% | 15.15% | 39.77% | n/a |
Hvivo | n/a | 0.00% | 18.92% | 37.50% | 34.69% | 1.54% | n/a |
Immupharma | 328 | -0.93% | -4.46% | -12.65% | -16.73% | 35.44% | n/a |
Indivior | 314 | -7.53% | -8.14% | -14.22% | -15.56% | -0.21% | n/a |
Ixico | n/a | -1.43% | -1.43% | -1.43% | 4.55% | -15.85% | n/a |
LungLife AI, Inc (DI) | n/a | -3.23% | -3.23% | -10.45% | -3.23% | -33.33% | n/a |
Maxcyte Inc (DI/REG S) | 330 | 0.00% | 0.00% | 0.00% | 3.93% | -5.13% | n/a |
Mereo Biopharma Group | n/a | 0.00% | -10.17% | -22.06% | -18.46% | -42.39% | n/a |
Motif Bio | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
N4 Pharma | n/a | 0.00% | -2.94% | 13.79% | 22.22% | -10.81% | n/a |
Nuformix | 322 | 8.11% | -2.44% | -2.44% | 5.26% | -48.72% | n/a |
Okyo Pharma Limited NPV | 403 | 0.00% | -31.71% | -30.00% | -9.68% | -74.07% | n/a |
Ondine Biomedical Inc. NPV (CDI) | n/a | -6.00% | -12.96% | -21.67% | -39.74% | -42.40% | n/a |
OptiBiotix Health | n/a | 0.00% | -1.39% | -11.25% | -15.48% | -29.70% | n/a |
Ovoca Bio (CDI) | n/a | 0.00% | 13.79% | 50.00% | 17.86% | 3.13% | n/a |
Oxford Biomedica | 125 | 0.69% | 7.32% | 5.01% | 13.05% | 21.01% | n/a |
Oxford Cannabinoid Technologies Holdings | n/a | 1.37% | 5.71% | 7.25% | -13.95% | -45.19% | n/a |
Oxford Nanopore Technologies | n/a | -9.26% | -1.48% | -14.51% | -25.10% | -35.75% | n/a |
Pfizer Inc. | n/a | 0.00% | 17.46% | 17.46% | 17.46% | 17.46% | n/a |
OJSC Pharmstandard GDR (Reg S) | n/a | 0.00% | -1.75% | 2.89% | -2.00% | 3.16% | n/a |
Plethora Solutions Holdings | n/a | 0.00% | -11.11% | -11.11% | 9.09% | -33.33% | n/a |
Poolbeg Pharma | n/a | 0.87% | 12.08% | 17.77% | 18.37% | 38.10% | n/a |
Proteome Sciences | 353 | 0.29% | 15.08% | 14.33% | 0.57% | -19.31% | n/a |
PureTech Health | n/a | 0.00% | 2.41% | -2.07% | -4.71% | 7.21% | n/a |
Quantum Pharma | n/a | 0.00% | 2.74% | 2.43% | 2.74% | 52.49% | n/a |
Redx Pharma | 278 | 8.11% | -21.57% | 33.33% | -46.67% | -51.22% | n/a |
ReNeuron Group | 394 | 0.00% | 0.00% | 0.00% | 0.00% | -13.46% | n/a |
Sareum Holdings | 594 | -13.93% | -1.87% | 105.88% | 81.03% | -47.50% | n/a |
Scancell Holdings | n/a | 0.00% | 0.52% | -4.95% | -6.34% | -8.57% | n/a |
Shield Therapeutics | n/a | -7.55% | -16.95% | -22.22% | -38.75% | -80.86% | n/a |
Shire Plc | n/a | 0.00% | 2.63% | 4.36% | 3.42% | 6.88% | n/a |
Silence Therapeutics | 177 | 0.00% | -1.65% | -0.93% | 5.94% | -9.17% | n/a |
Sinclair Pharma | n/a | 0.00% | 0.00% | 0.32% | 0.47% | 45.21% | n/a |
SkinBioTherapeutics | n/a | 0.00% | -5.13% | -7.50% | -14.75% | -27.45% | n/a |
Skyepharma | n/a | 0.00% | -1.94% | -4.47% | -6.39% | 17.35% | n/a |
Source BioScience | n/a | 0.00% | -4.11% | -1.41% | -1.41% | 2.19% | n/a |
Summit Therapeutics | n/a | 0.00% | -2.38% | -12.77% | -2.38% | -6.82% | n/a |
Synairgen | 510 | 2.97% | -0.15% | -8.47% | 27.47% | 12.75% | n/a |
Taihua | n/a | 0.00% | -30.00% | 59.09% | -46.15% | -72.00% | n/a |
The Therapist 0.25P | 304 | 0.00% | 3.23% | 3.23% | -8.57% | -51.52% | n/a |
Tiziana Life Sciences | n/a | 0.00% | 11.43% | 12.50% | 7.34% | -7.87% | n/a |
Valirx | 435 | -4.35% | -4.35% | -9.59% | -14.29% | -31.96% | n/a |
Vectura Group | 139 | 0.00% | 0.12% | -0.12% | 0.00% | 6.74% | n/a |
Verici DX | 429 | -6.45% | -9.38% | -6.45% | -21.62% | -23.68% | n/a |
Vernalis plc | n/a | 0.00% | 0.49% | 0.33% | 0.82% | -4.19% | n/a |
Verona Pharma | n/a | 0.00% | 4.76% | 4.76% | -15.38% | -24.14% | n/a |
Verseon Corporation (DI/REG S) | n/a | 0.00% | 96.72% | 73.91% | -48.94% | -67.74% | n/a |
Verseon Corporation (Reg S Cat 3) | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Yourgene Health | n/a | 0.00% | 0.98% | 0.98% | 5.10% | 139.53% | n/a |